… the biotechnology company's shares with a price target of … imaging technology company's shares to a buy rating with … Citi acknowledges that Pro Medicus shares trade on very high multiples … ;s shares with an improved price target of $5.25. UBS has …

… ;resilience in challenging conditions". UBS said its unique new dataset … cash return per annum," UBS said. "However, 12 months … ." At 1240 BST, the shares were up 4.2% at …

… versions of GLP-1 drugs. Shares have fallen nearly 60% in … for orforglipron. Matthew Weston, a UBS analyst, said he saw “clear … increasing around the world. The shares of GLP-1 drugmakers have … by just 27%. Eli Lilly shares are up by nearly 395% …

… ;buy' recommendation on Heineken shares, UBS has reduced its target price …

… year. Why are Wesfarmers shares still climbing? Wesfarmers reported … . According to the broker UBS, Wesfarmers is predicted to … of the stock? Wesfarmers shares have continued flying higher … Morgans analysts think the shares are slightly overvalued at current …

Indian shares climbed on Thursday, supported by … Indonesia, expanding its global footprint. Shares of Cochin Shipyard climbed 2% … . Avenue Supermarts rose 2% after UBS reiterated “buy” and raised the …

… September 18, after global brokerage UBS reiterated its “buy” rating on … closing price of ₹4,717. UBS, in its note, termed … , with still low penetration. UBS expects DMart to grow structurally … in March 2017, Avenue Supermarts shares have surged nearly 1,500% …

… on ASX dividend shares and undervalued ASX growth shares. He holds … institution that likes Steadfast. UBS describes this business as Australasia … result from the company, UBS noted an organic revenue … US, which UBS called a sizeable deal. UBS is forecasting …

… Jefferies analysts saw scope for shares to regain lost ground … free cash-flow outlook. Shares of the company had been … of the French government, European shares have managed to stay afloat … with some dents to sentiment. UBS equity strategists have raised their …

… . The primary reason Moderna shares gained yesterday was its announcement … buy rating. On Tuesday, UBS reiterated its buy rating on … . In a research note, UBS highlighted the lobbyist's … his first term. Furthermore, UBS believes that the upcoming Senate …